Published in Minerva Urol on September 25, 1979
Early insertion of inflatable prosthesis for intractable ischemic priapism: our experience and review of the literature. Int J Impot Res (2011) 2.17
Metabolic bone disease induced by prostate cancer: rationale for the use of bisphosphonates. J Urol (2001) 1.50
Transmembrane signaling in Dictyostelium. Methods Cell Biol (1987) 1.48
Renal cell cancer in presacral ectopic kidney: preoperative diagnostic imaging compared to surgical findings. Urol Int (2004) 1.46
Factors that influence peak bone mass formation: a study of calcium balance and the inheritance of bone mass in adolescent females. Am J Clin Nutr (1990) 1.43
Y-neobladder: an easy, fast, and reliable procedure. Urology (2004) 1.41
Effectiveness of nifedipine and deflazacort in the management of distal ureter stones. Urology (2000) 1.39
Identification and cyclic AMP-induced modification of the cyclic AMP receptor in Dictyostelium discoideum. J Biol Chem (1985) 1.16
The number of lymph nodes examined and staging accuracy in renal cell carcinoma. BJU Int (2003) 1.08
Bilateral adrenalectomy for Cushing's syndrome: a comparison between laparoscopy and open surgery. J Endocrinol Invest (2004) 1.05
[Angiolipoma of the cecum]. Minerva Chir (1996) 1.02
Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm. J Clin Invest (1997) 1.01
Prognostic value of the involvement of the urinary collecting system in renal cell carcinoma. Eur Urol (2004) 1.01
Increased intima-media thickness of the carotid artery wall, normal blood pressure profile and normal left ventricular mass in subjects with primary hyperparathyroidism. Eur J Endocrinol (2002) 1.00
Lipoprotein, apolipoprotein, and lipolytic enzyme changes following estrogen administration in postmenopausal women. J Lipid Res (1989) 0.97
Role of adjunctive medical therapy with nifedipine and deflazacort after extracorporeal shock wave lithotripsy of ureteral stones. Urology (2002) 0.92
Immunohistochemical assessment of Ki-67 in the differential diagnosis of adrenocortical tumors. Urology (2001) 0.91
Monoclonal antibody Ki-67 in the study of the proliferative activity of bladder carcinoma. J Urol (1992) 0.90
[Coagulation and fibrinolytic activity of blood from the corpus cavernosum]. Arch Ital Urol Nefrol Androl (1991) 0.88
Conditioned sensitization to the psychomotor stimulant cocaine. Ann N Y Acad Sci (1992) 0.88
cAMP receptors controlling cell-cell interactions in the development of Dictyostelium. Cold Spring Harb Symp Quant Biol (1985) 0.87
[Pelvic ultrasound monitoring of lymphocele in patients treated with radical prostatectomy]. Arch Ital Urol Androl (2000) 0.87
Does adrenal mass size really affect safety and effectiveness of laparoscopic adrenalectomy? Urology (2002) 0.87
Relationship between neuroendocrine features and prognostic parameters in human prostate adenocarcinoma. Ann Oncol (2001) 0.86
Noradrenergic vascular hyper-responsiveness in human hypertension is dependent on oxygen free radical impairment of nitric oxide activity. Circulation (2000) 0.86
The role of surgery in a case of diffuse mucormycosis with haematemesis and gastric necrosis. Ann R Coll Surg Engl (2014) 0.86
Circulating neuroendocrine markers in patients with prostate carcinoma. Cancer (2000) 0.85
Transperitoneal laparoscopic adrenalectomy: experience in 72 procedures. J Endourol (2001) 0.84
Randomized comparison of goserelin acetate versus mitomycin C plus goserelin acetate in previously untreated prostate cancer patients with bone metastases. Tumori (1998) 0.82
A case of gastric carcinoma revealed by a ureteral metastasis. Panminerva Med (1975) 0.82
Effects of hormonal replacement therapy in postmenopausal hypertensive patients. Maturitas (2001) 0.81
Potential clinical value of circulating chromogranin A in patients with prostate carcinoma. Ann Oncol (2001) 0.81
[Treatment of a solitary renal cyst using percutaneous drainage and repeat alcoholization]. Arch Ital Urol Androl (1996) 0.80
Mechanisms of rapid bone loss following cardiac transplantation. Osteoporos Int (1994) 0.80
[Use of the monoclonal antibody KI-67 in the study of the proliferative activity of urologic tumors. Preliminary data]. J Urol (Paris) (1987) 0.80
Primary dysmenorrhea, educational performance, and cognitive and affective variables in adolescent schoolgirls. Br J Educ Psychol (1982) 0.79
Electrophysiological patterns of oropharyngeal swallowing in multiple sclerosis. Clin Neurophysiol (2013) 0.79
Osteoblastic flare assessed by serum alkaline phosphatase activity is an index of short duration of response in prostate cancer patients with bone metastases submitted to systemic therapy.Gruppo Onco Urologico Piemontese (G.O.U.P). Anticancer Res (1998) 0.78
[Indications for correction of varicocele]. Arch Ital Urol Nefrol Androl (1990) 0.78
Proposal of an improved prognostic classification for pT3 renal cell carcinoma. J Urol (2008) 0.78
A high-throughput assay for the detection of Tyr-phosphorylated proteins in urine of bladder cancer patients. Biochim Biophys Acta (2013) 0.78
[Determination of LH and FSH levels before and after prostatic adenomectomy (author's transl)]. J Urol Nephrol (Paris) (1980) 0.77
Effects of the somatostatin analog lanreotide on the circulating levels of chromogranin-A, prostate-specific antigen, and insulin-like growth factor-1 in advanced prostate cancer patients. Prostate (2001) 0.77
[Dose-response study of bunazosin in the treatment of light-to-moderate arterial hypertension]. Minerva Cardioangiol (1993) 0.77
Haemodynamic and metabolic effects of rilmenidine in hypertensive patients with metabolic syndrome X. A double-blind parallel study versus amlodipine. J Hypertens (2000) 0.77
The challenge of kidney lesions in von Hippel-Lindau disease. Contrib Nephrol (2001) 0.77
Impairment of coronary circulation by acute hyperhomocysteinaemia and reversal by antioxidant vitamins. J Intern Med (2004) 0.77
Alterations in striatal dopamine overflow during rotational behavior induced by amphetamine, phencyclidine, and MK-801. Synapse (1997) 0.76
Pamidronate administration improves the secondary hyperparathyroidism due to "Bone Hunger Syndrome" in a patient with osteoblastic metastases from prostate cancer. Prostate (1997) 0.76
[Orgotein iontophoresis in the therapy of induratio penis plastica]. Minerva Med (1985) 0.75
Defining consciousness. Nature (1992) 0.75
[Initial experiences with the Doppler method in the study of impotence]. Minerva Urol Nefrol (1985) 0.75
[Chemotherapy: its repercussions on fertility and potency]. Arch Ital Urol Androl (1999) 0.75
[Renal colic: symptoms manifesting an aorto-iliac aneurysm. Clinical case]. Minerva Urol Nefrol (1988) 0.75
[Re-biopsies of the prostate after endo-magnetic resonancen imaging (MRI) and spectroscopy (MRS) in patients with ASAP: preliminary results]. Urologia (2009) 0.75
[Proposal for a follow-up of patients with orthotopic neobladder]. Urologia (2010) 0.75
[Surgical interventions and andrological complications]. Arch Ital Urol Nefrol Androl (1991) 0.75
Changes in free and free-to-total prostate specific antigen after androgen deprivation or chemotherapy in patients with advanced prostate cancer. J Urol (1999) 0.75
[Transvaginal ultrasonography in the diagnosis of urethral diverticula]. J Urol (Paris) (1993) 0.75
[Avulsion of the penile skin: a conservative approach]. Urologia (2010) 0.75
[Our experience on the subject of intracavernous injection of papaverine]. Minerva Urol Nefrol (1987) 0.75
[Use of amikacin in renal pathology]. Minerva Urol (1981) 0.75
[Hypertensive patients with monolateral nephropathy of urologic importance. Prognostic evaluation]. Minerva Urol (1984) 0.75
[Significance of the eosin test in the evaluation of the vitality of spermatozoa]. Minerva Urol Nefrol (1985) 0.75
[Evolution and progress in bladder replacement]. Urologia (2010) 0.75
[Subclinical varicocele]. Minerva Urol Nefrol (1985) 0.75
[Retroperitoneoscopic nephropexy]. Urologia (2010) 0.75
[Reliability of transrectal echography in the early diagnosis of prostatic carcinoma: our experience]. Arch Ital Urol Nefrol Androl (1991) 0.75
[The use of artificial pacemakers in medical practice]. Arch Sci Med (Torino) (1969) 0.75
Results of long term treatment of advanced prostatic cancer with the LHRH analogue buserelin. Prog Clin Biol Res (1987) 0.75
Laparoscopic diagnosis and management of acute intra-abdominal testicular torsion. J Urol (2001) 0.75
[Transvaginal repair of neobladder vaginal fistula]. Urologia (2010) 0.75
[Pneumoscrotum (preliminary note)]. Minerva Urol (1977) 0.75
[Post-traumatic thrombosis of the renal artery]. Minerva Urol (1979) 0.75
[2 cases of recurrence on perineal urethrostomy after emasculation for carcinoma of the penis]. Minerva Urol (1977) 0.75
[Results of hyperthermia on the bladder carcinomas of the dog (author's transl)]. J Urol Nephrol (Paris) (1977) 0.75
[Littoral hemangioma of the spleen]. Minerva Chir (2001) 0.75
[Inclusion body urethritis and Reiter's syndrome]. Minerva Urol (1978) 0.75
Vesico-coccygeal fistula revealing pelvic malakoplakia. Br J Urol (1992) 0.75
Plasma levels of testosterone, LH and FSH after prostatic adenomectomy. Andrologia (1981) 0.75
Characterization and leaching of NiCd and NiMH spent batteries for the recovery of metals. Waste Manag (2005) 0.75
[Renal liposarcoma. Description of a case]. Minerva Urol Nefrol (1988) 0.75
[Problems in emergency surgery: considerations on renal lesions caused by penetrating wounds]. Minerva Urol (1980) 0.75
Cortical-sparing laparoscopic adrenalectomy in a patient with multiple endocrine neoplasia type IIA. Horm Res (2002) 0.75
[Role of the vesico-urethral anastomosis biopsy in the diagnosis of local recurrence following radical prostatectomy.Our experience]. Urologia (2010) 0.75
[Use of orgotein in the treatment of plastic penile induration]. Minerva Urol Nefrol (1988) 0.75
[Primary epithelial tumors of the renal pelvis. Critical review of 24 cases]. Minerva Urol (1970) 0.75